throbber

`
`
`
`
`
`
`
`
`
`
`
` Paper No. ____
`
`Filed: May 26, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`INNOPHARMA LICENSING, INC., INNOPHARMA LICENSING LLC,
`INNOPHARMA INC., INNOPHARMA LLC, MYLAN PHARMACEUTICALS
`INC., and MYLAN INC.,
`Petitioner
`v.
`
`
`
`
`
`
`
`
`
`
`
` SENJU PHARMACEUTICAL CO., LTD., BAUSCH & LOMB, INC., and
`BAUSCH & LOMB PHARMA HOLDINGS CORP.,
`Patent Owner
`_________________
`Case IPR2015-00902
`U.S. Patent 8,669,290
`_________________
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`

`Case IPR2015-00902
`U.S. Patent 8,669,290
`Further to 37 C.F.R. § 42.63(e), Patent Owner Senju Pharmaceutical Co.,
`
`Ltd., hereby submits a current listing of Senju Exhibits to counsel for Petitioner
`
`InnoPharma Licensing, Inc., InnoPharma Licensing LLC, InnoPharma Inc.,
`
`InnoPharma LLC, Mylan Pharmaceuticals Inc., and Mylan Inc.
`
`Exhibit 2006
`
`Description
`Exhibits
`Exhibit 2001 Transcript of Teleconference with the Board, dated April 15, 2015.
`Exhibit 2002 U.S. Patent No. 8,669,290 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-bromobenzoyl)phenylacetic
`acid.”
`Exhibit 2003 U.S. Patent No. 8,754,131 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-bromobenzoyl)phenylacetic
`acid.”
`Exhibit 2004 U.S. Patent No. 8,871,813 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-bromobenzoyl)phenylacetic
`acid.”
`Exhibit 2005 U.S. Patent No. 8,927,606 to Sawa et al., “Aqueous Liquid
`Preparation Containing 2-amino-3-(4-bromobenzoyl)phenylacetic
`acid.”
`InnoPharma’s Paragraph IV Notice Letter dated September 19,
`2014.
`InnoPharma’s Paragraph IV Notice Letter dated October 30, 2014.
`Exhibit 2007
`InnoPharma’s Paragraph IV Notice Letter dated March 27, 2015.
`Exhibit 2008
`Exhibit 2009 Complaint, Senju Pharm. Co., Ltd. et al. v. InnoPharma Licensing,
`Inc. et al., No. 14-cv-06893 (D.N.J. Nov. 3, 2014), ECF No. 1.
`Exhibit 2010 Complaint, Senju Pharm. Co., Ltd. et al. v. InnoPharma Licensing,
`Inc. et al., No. 15-cv-03240 (D.N.J. May 8, 2015), ECF No. 1.
`Exhibit 2011 Consolidated scheduling order, Senju Pharm. Co., Ltd. et al. v.
`InnoPharma Licensing, Inc. et al., No. 14-cv-06893 (D.N.J. April
`16, 2015), ECF No. 30.
`Exhibit 2012 Amended scheduling order, Senju Pharm. Co., Ltd. et al. v. Lupin,
`Ltd. et al., No. 14-cv-00667 (D.N.J. Feb. 27, 2015), ECF No. 63.
`Exhibit 2013 Prolensa® (bromfenac ophthalmic solution 0.07%) Prescribing
`Information.
`
`
`
`2
`
`

`

`Case IPR2015-00902
`U.S. Patent 8,669,290
`Exhibit 2014 U.S. Patent No. 5,630,793 to Rowe, “Aqueous Ophthalmic
`Sprays.”
`Exhibit 2015 Press Release by Bausch + Lomb, dated April 8, 2013, entitled
`“Bausch + Lomb Receives FDA Approval for Prolensa™
`(bromfenac ophthalmic solution) 0.07%.”
`Exhibit 2016 Lupin’s Paragraph IV Notice Letter dated May 13, 2014.
`Exhibit 2017 Metrics’ Paragraph IV Notice Letter dated June 26, 2014.
`Exhibit 2018 Paddock’s Paragraph IV Notice Letter dated December 15, 2014.
`Exhibit 2019 Apotex’s Paragraph IV Notice Letter dated December 10, 2014.
`Exhibit 2020 Masson et al., Stabilisation of ionic drugs through complexation
`with non-ionic and ionic cyclodextrins, 164 INT’L J.
`PHARMACEUTICS 45 (1998).
`Exhibit 2021 Loftsson et al., Pharmaceutical Applications of Cyclodextrins, 85
`J. PHARMACEUTICAL SCIENCES 1017 (1996).
`Exhibit 2022 HSBC Global Research Lupin Company Report, Feb. 3, 2014,
`http://www.lupin.com/pdf/14/20140203%20-
`%20Lupin%203QFY14%20-%20HSBC.pdf
`Exhibit 2023 APOTEX ALL PRODUCTS,
`https://www.apotex.com/us/en/products/search.asp?qt=All&qs=&t
`=All%20Products.
`Exhibit 2024 Consent judgment, Senju Pharm. Co., Ltd. et al. v. Apotex Inc. et
`al., No. 15-cv-00336 (D.N.J. May 18, 2015), ECF No. 26.
`Exhibit 2025 U.S. Patent No. 5,856,345 to Doi et al., “Method for Stabilizing
`Pranoprofen and Stable Liquid Preparation of Pranoprofen.”
`Exhibit 2026 Xibrom® Prescribing Information.
`Exhibit 2027 Bromday® Prescribing Information.
`Exhibit 2028 Drugs@FDA, Listing of FDA-approved bromfenac ophthalmic
`solution 0.09% products,
`http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?f
`useaction=Search.Overview&DrugName=BROMFENAC%20SO
`DIUM.
`Exhibit 2029 Sheryl Gay Stolberg, New Painkiller is Withdrawn After 4 Deaths,
`N.Y. TIMES, Jun. 23, 1998.
`Exhibit 2030 Baklayan et al., The ocular distribution of 14C-labeled bromfenac
`ophthalmic solution 0.07% in a rabbit model, CLINICAL 2014:8
`OPHTHALMOLOGY 1717 (2014).
`
`
`
`3
`
`

`

`
`
`
`
`Dated: May 26, 2015
`
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`Respectfully submitted,
`
`By: /Bryan C. Diner/
`Bryan C. Diner, Lead Counsel
`Reg. No. 32,409
`
`Counsel for Patent Owner
`
`
`
`
`
`4
`
`

`

`CERTIFICATE OF SERVICE
`
`Case IPR2015-00902
`U.S. Patent 8,669,290
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Updated Exhibit List and Exhibits 2002 - 2030 were served on May
`
`26, 2015, via email directed to counsel of record for the Petitioner at the following:
`
`Jitendra Malik
`jitty.malik@alston.com
`
`Bryan Skelton
`bryan.skelton@alston.com
`
`Lance Soderstrom
`lance.soderstrom@alston.com
`
`
`
`Date: May 26, 2015
`
`/Ashley F. Cheung/
`Ashley F. Cheung
`Case Manager
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`
`
`
`5
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket